Liver Cirrhosis Treatment Companies

Intercept Pharmaceuticals (US) Received breakthrough therapy designation from the FDA for their drug Obeticholic Acid (OCA) for the treatment of non-alcoholic steatohepatitis (NASH) with fibrosis.Partnered with research institutions to conduct Phase III clinical trials for OCA in combination with other therapies for advanced liver cirrhosis stages.

Gilead Sciences (US) Launched their antiviral drug Vemlidis® (Tenofovir Alafenamide) for the treatment of chronic hepatitis B infection, potentially preventing progression to cirrhosis in infected individuals.Continued clinical trials for their investigational anti-fibrotic drug GS-4941 as a potential treatment option for liver cirrhosis due to various causes.

Novartis (Switzerland) Initiated Phase II clinical trials for their novel anti-fibrotic drug PBI-454 with promising early results in reducing liver fibrosis in patients with NASH.Collaborated with patient advocacy groups to raise awareness about liver cirrhosis and advocate for improved access to treatment options.

Viking Therapeutics (US) Received Fast Track designation from the FDA for their drug VK5-2377, a potential first-in-class treatment for primary biliary cholangitis, a progressive liver disease that can lead to cirrhosis.Partnering with healthcare providers to develop clinical trial enrollment strategies and expand access to innovative treatment options for liver cirrhosis patients.

World Health Organization (WHO) Launched a global roadmap to eliminate viral hepatitis as a public health threat by 2030, emphasizing prevention, screening, and access to effective treatment for hepatitis B and C.Provided technical assistance and resources to low- and middle-income countries to strengthen their healthcare systems and improve management of liver cirrhosis patients.

List of Liver Cirrhosis Treatment Key Companies in The Market

• Pfizer, Inc. (US)


• Merck & Co., Inc. (Germany)


• Novartis AG (Switzerland)


• Hoffmann-La Roche Ltd (Switzerland)


• Takeda Pharmaceutical Company Limited (Japan)


• Gilead Sciences, Inc. (US)


• AstraZeneca (UK)


• Bayer AG (Germany)


• Sanofi (France)


• Shionogi Inc. (Japan)


• Promethera (Belgium)